Table 3  Selection of molecules investigated in ongoing clinical studies (July, 2020)
Name  Structure  Description  Recent trials
Azithromycin   Macrolide antibiotic  IRCT20200428047228N2
NCT04405921
EUCTR2020‐001605‐23‐ES
Favipiravir   Broad spectrum antiviral drug  NCT04434248
ChiCTR2000033491
NCT04425460
Triazavirin   Broad‐spectrum antiviral drug  ChiCTR2000030001
Umifenovir   Antiviral drug  IRCT20200523047550N1
IRCT20151227025726N15
IRCT20200325046859N2
Baloxavir marboxil   Antiviral drug  ChiCTR2000029548
ChiCTR2000029544
Remdesivir   Antiviral drug  NCT04431453
NCT04409262
NCT04410354
Ribavirin   Antiviral drug  IRCT20200324046850N2
ChiCTR2000030922
Lopinavir/ritonavir   Anti‐HIV combination medication  NCT04403100
NCT04376814
Celecoxib   COX‐2 selective NSAID  ChiCTR2000031630
Chloroquine   Antimalarial drug  EUCTR2020‐001441‐39‐IT
NCT04447534
NCT04443270
Hydroxychloroquine   Antimalarial drug  EUCTR2020‐001558‐23‐IT
EUCTR2020‐001441‐39‐IT
EUCTR2020‐001501‐24‐IT
Mefloquine   Antimalarial drug  EUCTR2020‐001194‐69‐ES
Ivermectin   Broad‐spectrum antiparasitic drug  NCT04445311
NCT04435587
NCT04431466
Colchicine   Broad‐spectrum anti‐inflammatory drug  NCT04416334
EUCTR2020‐001841‐38‐ES
IRCT20190810044500N5
Corticosteroids (misc.)   Broad‐spectrum anti‐inflammatory drug  IRCT20151227025726N17
NCT04395105
IRCT20120215009014N354
Pirfenidone   Antifibrotic, anti‐inflammatory drug  IRCT20200314046764N1
ChiCTR2000031138
Tranilast   Anti‐inflammatory drug  ChiCTR2000030002
Selinexor   Anticancer drug  NCT04355676
NCT04349098
EUCTR2020‐001411‐25‐GB
Valsartan   Angiotensin II receptor antagonist  DRKS00021732
NCT04335786
Dipyridamole   PDE3 inhibitor  NCT04424901 NCT04391179
Vidoflumidus (IMU‐838)   Investigational drug  EUCTR2020‐001264‐28‐HU
Azvudine   Investigational antiviral  ChiCTR2000032769
NCT04425772
ChiCTR2000030487
EIDD‐2801   Investigational antiviral  NCT04405570
NCT04405739
NCT04392219
John Wiley & Sons, Ltd. This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.